Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Alcidion GroupASX:ALC Intrinsic Value: Projected FCF is A$0.06 as of Sep. 02, 2026. The stock has 4 warning signs investors should review. Among 342 Healthcare Providers & Services companies, Alcidion Group ranks worse than 65.79% on this metric.
Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.
As of today (2026-09-02), Alcidion Group's Intrinsic Value: Projected FCF is A$0.06. The stock price of Alcidion Group is A$0.097. Therefore, Alcidion Group's Price-to-Intrinsic-Value-Projected-FCF of today is 1.6.
The historical rank and industry rank for Alcidion Group's Intrinsic Value: Projected FCF or its related term are showing as below:
ASX:ALC'
s Price-to-Projected-FCF Range Over the Past 10 Years
Min: 1.2 Med: 1.95 Max: 13.08
Current: 1.62
During the past 13 years, the highest Price-to-Intrinsic-Value-Projected-FCF of Alcidion Group was 13.08. The lowest was 1.20. And the median was 1.95.
ASX:ALC's Price-to-Projected-FCF is ranked worse than 65.79% of 342
companies
in the Healthcare Providers & Services industry
Industry Median: 1.08
vs ASX:ALC: 1.62
Alcidion Group (ASX:ALC) Intrinsic Value: Projected FCF Explanation
The growth multiple is capped between 8.35 and 17.74.
Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.
Alcidion Group's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as
Price-to-Intrinsic-Value-Projected-FCF
=
Share Price
/
Intrinsic Value: Projected FCF
=
0.097
/
0.058753683446874
=
1.65
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alcidion Group Intrinsic Value: Projected FCF Related Terms
Alcidion Group Intrinsic Value: Projected FCF Historical Data
* Premium members only.
The historical data trend for Alcidion Group's Intrinsic Value: Projected FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alcidion Group Intrinsic Value: Projected FCF Chart
ASX:ALC vs VEEV, BTSG, TEM: Intrinsic Value: Projected FCF Comparison
For the Health Information Services subindustry, Alcidion Group's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alcidion Group Price-to-Projected-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Alcidion Group's Price-to-Projected-FCF distribution charts can be found below:
* The bar in red indicates where Alcidion Group's Price-to-Projected-FCF falls into.
Alcidion Group Intrinsic Value: Projected FCF Calculation
Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.
The details of how we calculate the intrinsic value of stocks are described in detail here.
This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Intrinsic Value: Projected FCF of A$0.06 mean?
Alcidion Group (ASX:ALC) has a Intrinsic Value: Projected FCF of A$0.06 as of Sep. 02, 2026. Intrinsic Value: Projected FCF is the stock value based on a projected free cash flow model. View historical data on Alcidion Group and its competitors. According to the industry distribution chart, Alcidion Group ranks #225 out of 342 companies in the Healthcare Providers & Services industry, placing it in the top 65.8%.
Is Alcidion Group's Intrinsic Value: Projected FCF too high?
Alcidion Group's current Intrinsic Value: Projected FCF is A$0.06. Based on the distribution chart, Alcidion Group ranks #225 out of 342 companies in the Healthcare Providers & Services industry, which is below the industry midpoint.
How does Alcidion Group's Intrinsic Value: Projected FCF compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Alcidion Group ranks #225 out of 342 companies for Intrinsic Value: Projected FCF. This places Alcidion Group in the lower half of its industry. The industry median Intrinsic Value: Projected FCF is 1.08. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Intrinsic Value: Projected FCF for a Healthcare Providers & Services company?
The median Intrinsic Value: Projected FCF among Healthcare Providers & Services companies is 1.08, based on 342 companies in the industry. Companies in the top quartile (top 25%) have a Intrinsic Value: Projected FCF significantly above this median, while those in the bottom quartile fall well below. However, Intrinsic Value: Projected FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Intrinsic Value: Projected FCF mean?
A high Intrinsic Value: Projected FCF can signal that a stock is expensive relative to its fundamentals. Intrinsic Value: Projected FCF is the stock value based on a projected free cash flow model. View historical data on Alcidion Group and its competitors. For the Healthcare Providers & Services industry, the median Intrinsic Value: Projected FCF is 1.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alcidion Group's current Intrinsic Value: Projected FCF is A$0.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alcidion Group stock overvalued right now?
Based on GuruFocus' analysis, Alcidion Group (ASX:ALC) is currently considered Fairly Valued. The stock's GF Value™ is A$0.10, compared to a current price of A$0.10 — trading 3% below its estimated fair value. The current Intrinsic Value: Projected FCF is A$0.06. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Intrinsic Value: Projected FCF calculated?
Intrinsic Value: Projected FCF is calculated from a company's financial statements. For Alcidion Group (ASX:ALC), the current Intrinsic Value: Projected FCF is A$0.06 as of Sep. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Alcidion Group Ltd is a provider of intelligent informatics software. It offers a fully integrated digital patient care platform that includes a clinical decision support (CDS) system, Electronic Patient Record (EPR), and Patient Administration System (PAS). Alcidion is engaged in the development and licensing of its own healthcare software products (Miya Precision and its associated modules, including Miya Observations, Flow, Task Management and PAS), the reselling of healthcare software products from its strategic partners, and the delivery of product implementation, product support and maintenance, systems integration and data analysis services to healthcare customers in the United Kingdom, Australia, and New Zealand. The company generates maximum revenue from the United Kingdom.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:ALC has been successfully added to your 
